Clinical Trial Update: Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating Dysport for urinary incontinence due to neurogenic detrusor overactivity related to spinal cord injury or multiple sclerosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Urinary Incontinence

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Urinary Incontinence, Overactive Bladder | Phase 3 | Status: TERMINATED | Results posted: 2021-06-16